Literature DB >> 6346002

Does day-long absolute hypoinsulinemia characterize the patient with non-insulin-dependent diabetes mellitus?

G Liu, A Coulston, Y D Chen, G M Reaven.   

Abstract

Plasma glucose and insulin responses to a standard oral glucose tolerance test (75 g of glucose) and to mixed meals were compared in 15 normal subjects and 15 patients with non-insulin-dependent diabetes mellitus (NIDDM). Fasting plasma glucose levels were above 140 mg/dL in all patients with NIDDM, and the two groups were weight matched. Plasma glucose levels were significantly higher in patients with NIDDM throughout the glucose tolerance test, and this was associated with a marked reduction in plasma insulin response. Plasma glucose levels were also higher in patients with NIDDM when measured hourly from 8 AM to 5 PM (mixed meals were consumed at 8 AM and 12 PM), but the plasma insulin concentration of the two groups were similar. Thus, the day-long circulating insulin levels of patients with NIDDM are not reduced. Consequently, these patients cannot be considered to be absolutely insulin deficient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346002     DOI: 10.1016/0026-0495(83)90104-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.

Authors:  K Ratheiser; W Reitgruber; M Komjati; P Bratusch-Marrain; H Vierhapper; W K Waldhäusl
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

2.  Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications.

Authors:  I R Sinay; P Arias; M A Schnitman; S A Damilano; M C Faingold; J A Moguilevsky
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

Review 3.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

4.  Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.

Authors:  A Golay; R A DeFronzo; E Ferrannini; D C Simonson; D Thorin; K Acheson; D Thiébaud; B Curchod; E Jéquier; J P Felber
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

Review 5.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

Review 6.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

7.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Authors:  C Bogardus; S Lillioja; B V Howard; G Reaven; D Mott
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey.

Authors:  B C Hansen; N L Bodkin
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

9.  Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.

Authors:  A V Zavala; L E Fabiano de Bruno; A I Cardoso; A H Mota; M Capucchio; E Poskus; L Fainboim; J C Basabe
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

10.  FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS.

Authors:  Gino B Ferraro; Ahmed Ali; Alba Luengo; David P Kodack; Amy Deik; Keene L Abbott; Divya Bezwada; Landry Blanc; Brendan Prideaux; Xin Jin; Jessica M Posada; Jiang Chen; Christopher R Chin; Zohreh Amoozgar; Raphael Ferreira; Ivy X Chen; Kamila Naxerova; Christopher Ng; Anna M Westermark; Mark Duquette; Sylvie Roberge; Neal I Lindeman; Costas A Lyssiotis; Jens Nielsen; David E Housman; Dan G Duda; Elena Brachtel; Todd R Golub; Lewis C Cantley; John M Asara; Shawn M Davidson; Dai Fukumura; Véronique A Dartois; Clary B Clish; Rakesh K Jain; Matthew G Vander Heiden
Journal:  Nat Cancer       Date:  2021-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.